Literature DB >> 3339802

Relapse of herpes simplex encephalitis after conventional acyclovir therapy.

K E VanLandingham1, H B Marsteller, G W Ross, F G Hayden.   

Abstract

Acyclovir sodium is the drug of choice for the treatment of herpes simplex encephalitis. We treated an immunocompetent patient with a ten-day course of intravenous acyclovir sodium at the recommended dosage of 10 mg/kg every eight hours for clinically apparent herpes simplex encephalitis. After marked improvement, his condition deteriorated four days after completing acyclovir therapy. A subsequent brain biopsy specimen disclosed acyclovir-sensitive herpes simplex virus type 1. A longer duration of acyclovir therapy (14 to 21 days) should be considered for treating herpes simplex encephalitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339802

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Herpes simplex encephalitis with relapse.

Authors:  M G Pike; C R Kennedy; B G Neville; M Levin
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 3.  Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

Authors:  R J Whitley
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 4.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 5.  Infections in Neurocritical Care.

Authors:  John C O'Horo; Priya Sampathkumar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

6.  Unusual course of herpes simplex virus encephalitis after acyclovir therapy.

Authors:  W Preiser; B Weber; G Klös; P A Fischer; H W Doerr
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

Review 7.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 8.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Retropharyngeal abscess.

Authors:  M Coulthard; D Isaacs
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

10.  Relapse of herpes simplex encephalitis after acyclovir therapy.

Authors:  P Nicolaidou; N Iacovidou; S Youroukos; T Liacopoulou-Tsitsipi; C Kattamis
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.